Skip to content
Business Segments · Acquisitions

Life Sciences Solutions — Acquisitions

Thermo Fisher Scientific Life Sciences Solutions — Acquisitions remained flat by 0.0% to $525.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 8.7%, from $575.5M to $525.25M. Over 4 years (FY 2021 to FY 2025), Life Sciences Solutions — Acquisitions shows an upward trend with a 7.7% CAGR.

Analysis

StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025Feb 26, 2026

How to read this metric

Higher spending indicates an aggressive growth strategy, while lower spending may signal a focus on organic growth or debt reduction.

Detailed definition

The total capital deployed by the Life Sciences Solutions segment to purchase other companies or business units. This me...

Peer comparison

Standard for companies in the highly fragmented life sciences and diagnostics industry.

Metric ID: tmo_segment_life_sciences_solutions_acquisitions

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$1.56B$0$0$2.3B$2.1B
YoY Change-100.0%-8.7%
Range$0$2.3B
CAGR+7.7%
Avg YoY Growth-54.4%
Median YoY Growth-54.4%

Frequently Asked Questions

What is Thermo Fisher Scientific's life sciences solutions — acquisitions?
Thermo Fisher Scientific (TMO) reported life sciences solutions — acquisitions of $525.25M in Q4 2025.
How has Thermo Fisher Scientific's life sciences solutions — acquisitions changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — acquisitions decreased by 8.7% year-over-year, from $575.5M to $525.25M.
What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — acquisitions?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's life sciences solutions — acquisitions has grown at a 7.7% compound annual growth rate (CAGR), from $1.56B to $2.1B.
What does life sciences solutions — acquisitions mean?
The total dollar amount spent on acquiring new businesses within the life sciences segment.